Perrigo Company PRGO today announced that it has signed a definitive merger agreement and has
completed the acquisition of Cobrek Pharmaceuticals, Inc. (Cobrek), a
privately-held, Chicago, Illinois-based drug development company, for
approximately $45 million on a cash free and debt free basis.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in